.png){kind=icon}
返回
Bayesian methods: a potential path forward for sepsis trials
.png){kind=icon}
OA
AI
DOI：10.1186/s13054-023-04717-x.png)
.png){kind=icon}
.png){kind=icon}
分享.png){kind=icon}
收藏
摘要
En 中文
BackgroundGiven the success of recent platform trials for COVID-19, Bayesian statistical methods have become an option for complex, heterogenous syndromes like sepsis. However, study design will require careful consideration of how statistical power varies using Bayesian methods across different choices for how historical data are incorporated through a prior distribution and how the analysis is ultimately conducted. Our objective with the current analysis is to assess how different uses of historical data through a prior distribution, and type of analysis influence results of a proposed trial that will be analyzed using Bayesian statistical methods.MethodsWe conducted a simulation study incorporating historical data from a published multicenter, randomized clinical trial in the US and Canada of polymyxin B hemadsorption for treatment of endotoxemic septic shock. Historical data come from a 179-patient subgroup of the previous trial of adult critically ill patients with septic shock, multiple organ failure and an endotoxin activity of 0.60-0.89. The trial intervention consisted of two polymyxin B hemoadsorption treatments (2 h each) completed within 24 h of enrollment.ResultsIn our simulations for a new trial of 150 patients, a range of hypothetical results were observed. Across a range of baseline risks and treatment effects and four ways of including historical data, we demonstrate an increase in power with the use of clinically defensible incorporation of historical data. In one possible trial result, for example, with an observed reduction in risk of mortality from 44 to 37%, the probability of benefit is 96% with a fixed weight of 75% on prior data and 90% with a commensurate (adaptive-weighting) prior; the same data give an 80% probability of benefit if historical data are ignored.ConclusionsUsing Bayesian methods and a biologically justifiable use of historical data in a prior distribution yields a study design with higher power than a conventional design that ignores relevant historical data. Bayesian methods may be a viable option for trials in critical care medicine where beneficial treatments have been elusive.
Keyword:
Septic shock
Endotoxemia
Endotoxin septic shock
Statistical methods
Polymyxin-B
Hemadsorption
Trial simulation
AI总结
对已上传原文的论文进行重点信息的提取，主要内容包括：简要概述、研究摘要、背景介绍、关键亮点、图文解析、展望与总结。
期刊
IF:
9.3
论文数:
1.0W
被引数:
3.8W
机构
查看更多机构
引用论文
Transitioning from Pediatric to Adult Care: The Role of an Education Curriculum for Adolescents and Young Adults with Sickle Cell Disease.png)
Blood
OAAI
BloodIF0
OAAI分享收藏Kinetic analysis of sodium channel block by internal methylene blue in pronased crayfish giant axonsOAAI
OAAI分享收藏Derivation, Validation, and Potential Treatment Implications of Novel Clinical Phenotypes for Sepsis脓毒症新临床表型的推导、验证和潜在治疗意义OAAI
OAAI分享收藏The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)脓毒症和脓毒症休克定义的第三次国际共识 (Sepsis-3)OAAI
OAAI分享收藏 查看更多内容